PROCEPT INC
4, 1998-09-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: PROCEPT INC, 4, 1998-09-10
Next: PROCEPT INC, 4, 1998-09-10




UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person

Michael S. Weiss
787 Seventh Avenue, 48th Floor
New York, New York 10019

2. Issuer Name and Ticker or Trading Symbol
   Procept, Inc. -- PRCTC

3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   08/98
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   (X) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)

7. Individual or Joint/Group Filing (Check Applicable Line)
   ( ) Form filed by One Reporting Person
   (X) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
- -----------------------------------------------------------------------------------------------------------------------------------|
                           |      |    | |                  |   |           |                   |      |                           |
                           |      |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|


<PAGE>

<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------|
Placement Option (1)  |$110,000|8/10/|J(2)| |0.6699(1)  |A  |10/9/|4/9/ |Units(1)    |2.967  |(2)    |0.6699(1)   |D  |            |
                      |        |98(2)|    | |           |   |98   |03   |            |       |       |            |(2)|            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Advisory Option (1)   |$110,000|8/10/|J(3)| |3.2087(1)  |A  |10/9/|4/9/ |Units(1)    |3.2087 |(3)    |3.2087(1)   |D  |            |
                      |        |98(3)|    | |           |   |98   |03   |            |       |       |            |(3)|            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
See Attachment 

(1)  The Placement Option and Advisory Option are options to purchase units each
     consisting  of (i) 20,000  shares of Common Stock and (ii) Class C Warrants
     to purchase 20,000 shares of Common Stock.
(2)   Pursuant to a Placement Agency Agreement  between the Issuer and Paramount
      Capital,   Inc.,   Paramount  Capital  Inc.  designated   recipients  (the
      "Paramount  Option  Designees")  of the Placement  Options.  Mr. Weiss was
      among the Paramount Option Designees and received such Placement Option in
      connection  with  a  private   placement  (the  "Private   Placement")  of
      securities  of the  Issuer  of  which  Paramount  Capital,  Inc.  acted as
      placement agent.
(3)   Pursuant  to  a  Financial  Advisory  Agreement  between  the  Issuer  and
      Paramount Capital,  Inc.,  Paramount Capital,  Inc. designated  recipients
      (the  "Paramount  Advisory  Option  Designees")  of the Advisory  Options.
      Hawkins Group,  LLC, of which Mr. Weiss is Managing Member,  was among the
      Paramount  Advisory Option Designees and received such Advisory Options in
      connection  with a private  placement  of  securities  of the Issuer.  The
      Advisory Options become exerciseable within 60 days of August 10, 1998.


**SIGNATURE OF REPORTING PERSON
/s/ Michael S. Weiss
- -----------------------------
Name: Michael S. Weiss,
Individually, and as Managing Member of
Hawkins Group, LLC


DATE
09/10/98

**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed.
          If space provided is insufficient, see Instruction 6 for procedure.


Potential persons who are to respond to the collection of information  contained
in this form are not  required to respond  unless the form  displays a currently
valid OMB Number.


<PAGE>

                                  Attachment A


Reporting Persons:                  Michael S. Weiss (the designated filer); and

                                    Hawkins Group, LLC
                                    787 Seventh Avenue, 48th Floor
                                    New York, NY  10019

Issuer:                             Procept Inc. (PRCT)

Statement For:                      August / 1998

      Michael  S.  Weiss is  Managing  Member  of  Hawkins  Group,  LLC and is a
Director of the  Issuer.  Each of the  Reporting  Persons  disclaims  beneficial
ownership  of the  securities  held by the other,  except to the extent of their
pecuniary interest therein, if any.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission